Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2017
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
Martin Puhr, Julia Hoefer, Andrea Eigentler, et al.
Scientific Reports
|
June 21, 2026
UCA1 copy number gain in serum cfDNA predicts next-generation antiandrogen resistance in metastatic castration-resistant prostate cancer
Anita Csizmarik, Áron Soós, Melinda Váradi, et al.
BJU International
|
May 27, 2018
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer
Tibor Szarvas, Sabina Sevcenco, Orsolya Módos, et al.
Molecular Oncology
|
June 25, 2020
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe
Stanislav Drápela, Prashant Khirsariya, Wytske M van Weerden, et al.
Molecular Cancer Therapeutics
|
September 27, 2018
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
Florian Handle, Martin Puhr, Georg Schaefer, et al.
Endocrine-Related Cancer
|
March 18, 2010
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
Lei Gu, Paraskevi Vogiatzi, Martin Puhr, et al.
The American Journal of Pathology
|
August 21, 2024
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer
Maximilian P Brandt, Olesya Vakhrusheva, Hubert Hackl, et al.
Oncogene
|
May 15, 2024
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, et al.
International Journal of Cancer
|
June 11, 2022
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer
Anita Csizmarik, Dávid Keresztes, Nikolett Nagy, et al.
Cell Reports. Medicine
|
January 23, 2024
Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer
Jing Wang, Jing Wei, Tianjie Pu, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2017
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
Martin Puhr, Julia Hoefer, Andrea Eigentler, et al.
Scientific Reports
|
June 21, 2026
UCA1 copy number gain in serum cfDNA predicts next-generation antiandrogen resistance in metastatic castration-resistant prostate cancer
Anita Csizmarik, Áron Soós, Melinda Váradi, et al.
BJU International
|
May 27, 2018
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer
Tibor Szarvas, Sabina Sevcenco, Orsolya Módos, et al.
Molecular Oncology
|
June 25, 2020
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe
Stanislav Drápela, Prashant Khirsariya, Wytske M van Weerden, et al.
Molecular Cancer Therapeutics
|
September 27, 2018
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
Florian Handle, Martin Puhr, Georg Schaefer, et al.
Endocrine-Related Cancer
|
March 18, 2010
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
Lei Gu, Paraskevi Vogiatzi, Martin Puhr, et al.
The American Journal of Pathology
|
August 21, 2024
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer
Maximilian P Brandt, Olesya Vakhrusheva, Hubert Hackl, et al.
Oncogene
|
May 15, 2024
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer
Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, et al.
International Journal of Cancer
|
June 11, 2022
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer
Anita Csizmarik, Dávid Keresztes, Nikolett Nagy, et al.
Cell Reports. Medicine
|
January 23, 2024
Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer
Jing Wang, Jing Wei, Tianjie Pu, et al.
Page
of 7